Support Line: 0800 002 9002
General Enquiries: 01223 870008

Latest News

On this page you will find all the latest news from new drug treatments through to developments and announcements from Kidney Cancer UK.
Pharma’s partner for phase Ib of RCC trial

Pharma’s partner for phase Ib of RCC trial

Merck partners with HiberCell for Phase Ib renal carcinoma trial The Phase Ib trial will evaluate the ...
Medical Alert Card now available

Medical Alert Card now available

We are pleased to offer these Medical Alert Card free of charge to kidney cancer patients which may be of help in ...
What Is SABR – Webinar

What Is SABR – Webinar

We are delighted to invite you to our next Living With Kidney Cancer Webinar on Tuesday 28th November at 6pm on ...
Charlie Peschardt’s Blog

Charlie Peschardt’s Blog

This is a blog from Charlie Peschardt Charlie is a veteran of the Royal Navy’s Commando helicopter force, was ...
Highest risk patients with RCC benefit from adjuvant everolimus

Highest risk patients with RCC benefit from adjuvant everolimus

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell ...
Dovitinib Companion Diagnostic Shows Results in RCC

Dovitinib Companion Diagnostic Shows Results in RCC

The drug response predictor companion diagnostic for dovinitib (DRP-Dovitinib) demonstrates potential to identify ...
No results found.

Support Line

OPEN 7 DAYS A WEEK

0800 002 9002